| 000 | 01758 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514050316.0 | ||
| 264 | 0 | _c20021108 | |
| 008 | 200211s 0 0 eng d | ||
| 022 | _a1537-6591 | ||
| 024 | 7 |
_a10.1086/343047 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSpradling, P | |
| 245 | 0 | 0 |
_aDrug-drug interactions in inmates treated for human immunodeficiency virus and Mycobacterium tuberculosis infection or disease: an institutional tuberculosis outbreak. _h[electronic resource] |
| 260 |
_bClinical infectious diseases : an official publication of the Infectious Diseases Society of America _cNov 2002 |
||
| 300 |
_a1106-12 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xtherapeutic use |
| 650 | 0 | 4 | _aAntiretroviral Therapy, Highly Active |
| 650 | 0 | 4 | _aDisease Outbreaks |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInstitutional Practice |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMycobacterium tuberculosis _xdrug effects |
| 650 | 0 | 4 | _aPrisoners |
| 650 | 0 | 4 |
_aRifabutin _xtherapeutic use |
| 650 | 0 | 4 |
_aTuberculosis _xdrug therapy |
| 700 | 1 | _aDrociuk, D | |
| 700 | 1 | _aMcLaughlin, S | |
| 700 | 1 | _aLee, L M | |
| 700 | 1 | _aPeloquin, C A | |
| 700 | 1 | _aGallicano, K | |
| 700 | 1 | _aPozsik, C | |
| 700 | 1 | _aOnorato, I | |
| 700 | 1 | _aCastro, K G | |
| 700 | 1 | _aRidzon, R | |
| 773 | 0 |
_tClinical infectious diseases : an official publication of the Infectious Diseases Society of America _gvol. 35 _gno. 9 _gp. 1106-12 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1086/343047 _zAvailable from publisher's website |
| 999 |
_c12194078 _d12194078 |
||